FranΓ§aisπ See the interactive version (live chart) β
| Metric | Value | What it means |
|---|---|---|
| P/E (price / earnings) | 42.5 | The higher, the more growth the market expects. |
| Forward P/E | 30.4 | On next year's expected earnings. Lower than current P/E = rising earnings. |
| PEG (P/E Γ· growth) | 1.61 | Below 1 = cheap given growth; above 2 = expensive. |
| Net margin | 28% | Share of revenue that ends up as profit. |
| Revenue growth | 18% | Pace of revenue growth. |
| Price-to-book | 7.2 | Price relative to book value. |
| Market cap | $131.5 B | Total market value of the company. |
| Dividend yield | β | No dividend currently. |
| Year | Revenue | Net income | Net margin |
|---|---|---|---|
| 2022 | $6.2 B | $1.3 B | 21% |
| 2023 | $7.1 B | $1.8 B | 25% |
| 2024 | $8.4 B | $2.3 B | 28% |
| 2025 | $10.1 B | $2.9 B | 28% |
π Open the interactive Intuitive Surgical page (charts, live news) β
Intuitive Surgical has a P/E of 42.5 (forward P/E 30.4) and a PEG of 1.61. A PEG below 1 is rather cheap given growth, above 2 is expensive. Verdict: reasonable valuation.
Intuitive Surgical's net margin is about 28% β the share of revenue that ends up as net profit.
Latest known revenue: $10.1 B for net income of $2.9 B. The year-by-year breakdown is in the income statement above.
Intuitive Surgical (ISRG) has a market cap of about $131.5 B.
No, Intuitive Surgical does not currently pay a dividend (it reinvests earnings).
JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best β on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.
Explore JPI Invest for free β How it works: the method β
β οΈ Educational information, not investment advice. Data: Yahoo Finance, recomputed by JPI Invest. A stock can be Β« cheap Β» for a bad reason.